Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

LUCENTIS vs PAVBLU

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. LUCENTIS and PAVBLU are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

lucentispavblu

Rating

70/100
72/100

Pharmacy pays

—
—

Type

RX
RX

Active ingredient

RANIBIZUMAB
AFLIBERCEPT-AYYH

Manufacturer

Genentech Inc
Amgen Inc

Dosage forms

Injectable
Injectable

Drug class

Vascular Endothelial Growth Factor Inhibitor
—

Boxed warning

None
None

Treats

Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion
Diabetic Retinopathy, Macular Edema

Frequently asked questions

Which is better-rated, Lucentis or Pavblu?

By our independent rating, Pavblu scores higher — 3.6 vs 3.5 out of 5 for Lucentis. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Lucentis and Pavblu?

Lucentis contains Ranibizumab, while Pavblu contains Aflibercept-Ayyh — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.